174 related articles for article (PubMed ID: 35459951)
1. Comparative Efficacy and Safety of Lacosamide and Oxcarbazepine for Seizure Control in Children with Newly Diagnosed Solitary Neurocysticercosis.
Sharawat IK; Panda PK; Kumar V; Sherwani P
J Trop Pediatr; 2022 Apr; 68(3):. PubMed ID: 35459951
[TBL] [Abstract][Full Text] [Related]
2. Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice.
Załuska-Ogryzek K; Marzęda P; Wróblewska-Łuczka P; Florek-Łuszczki M; Plewa Z; Bojar H; Zolkowska D; Łuszczki JJ
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073930
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Seizure Characteristics and Recurrence Rates in Children with Viable Parenchymal Neurocysticercosis and Tuberculoma in India.
Panda PK; Ramachandran A; Sharawat IK; Sherwani P; Bhat NK
Am J Trop Med Hyg; 2022 Oct; 107(4):833-840. PubMed ID: 36037862
[TBL] [Abstract][Full Text] [Related]
4. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the efficacy and influencing factors of sodium channel blockers in the treatment of focal epilepsy in infants under 6 months of age].
Ma YP; Deng J; Fu ZR; Chen CH; Wang XH; Wang X; Weng JW; Shen YH
Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):983-988. PubMed ID: 37899337
[No Abstract] [Full Text] [Related]
7. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
[TBL] [Abstract][Full Text] [Related]
8. Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open-label, randomized study.
Zhu H; Deng X; Feng L; Lian Y; Han X; Guo Z; Gou Y; Du Y; Xie L; Yao D; Liu Y; Wu Q; Lan S; Liu K; Zhan P; Wang X; Dang J; Hou Y; Chen K; Zhu Y; Shi Y; Yu Y; Xiao B; Zhu S; Meng H
CNS Neurosci Ther; 2022 Jul; 28(7):1072-1080. PubMed ID: 35429132
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
[TBL] [Abstract][Full Text] [Related]
10. Lacosamide add-on therapy for focal epilepsy.
Babar RK; Bresnahan R; Gillespie CS; Michael BD
Cochrane Database Syst Rev; 2021 May; 5(5):CD008841. PubMed ID: 33998660
[TBL] [Abstract][Full Text] [Related]
11. Retrospective comparison of efficacy of levetiracetam and lacosamide add-on treatments in patients with partial onset seizure.
Acar T; Aras YG
Ideggyogy Sz; 2018 May; 71(5-06):197-204. PubMed ID: 29889462
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
[TBL] [Abstract][Full Text] [Related]
13. Perampanel and lacosamide monotherapy in pediatric patients with newly diagnosed focal epilepsy: A prospective study evaluating efficacy, tolerability, and behavior.
Zhou R; Qu R; Liu M; Huang DP; Zhou JY; Chen Y; Chen XQ
Epilepsy Behav; 2023 Sep; 146():109353. PubMed ID: 37481960
[TBL] [Abstract][Full Text] [Related]
14. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P
Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
[TBL] [Abstract][Full Text] [Related]
15. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
16. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.
Mo F; Meletti S; Belcastro V; Quadri S; Napolitano M; Bello L; Dainese F; Scarpelli M; Florindo I; Mascia A; Pauletto G; Bruno F; Pellerino A; Giovannini G; Polosa M; Sessa M; Conti Nibali M; Di Gennaro G; Gigli GL; Pisanello A; Cavallieri F; Rudà R
J Neurooncol; 2022 May; 157(3):551-559. PubMed ID: 35397759
[TBL] [Abstract][Full Text] [Related]
17. Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur, China.
Zhao T; Li HJ; Ma L; Feng J; Wang TT; Yu J; Sun L; Sun Y; Yu LH
Epilepsy Behav; 2021 Apr; 117():107814. PubMed ID: 33611102
[TBL] [Abstract][Full Text] [Related]
18. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of treatment with lacosamide in children: Postmarketing experience from the Middle East.
Hmaimess G; Sabbagh S; Dirani M; Hotait M; Beydoun AA; Nasreddine W
Seizure; 2020 Jul; 79():75-79. PubMed ID: 32422546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
